Human Gene HTT (ENST00000355072.11_5) from GENCODE V47lift37
Description: huntingtin, transcript variant 2 (from RefSeq NM_002111.8)Gencode Transcript: ENST00000355072.11_5Gencode Gene: ENSG00000197386.14_22Transcript (Including UTRs) Position: hg19 chr4:3,076,408-3,245,684 Size: 169,277 Total Exon Count: 67 Strand: +Coding Region Position: hg19 chr4:3,076,553-3,241,786 Size: 165,234 Coding Exon Count: 67
Data last updated at UCSC: 2024-08-22 23:36:26
Sequence and Links to Tools and Databases
Comments and Description Text from UniProtKB
ID: HD_HUMAN DESCRIPTION: RecName: Full=Huntingtin; AltName: Full=Huntington disease protein; Short=HD protein;FUNCTION: May play a role in microtubule-mediated transport or vesicle function.SUBUNIT: Binds SH3GLB1 (By similarity). Interacts through its N- terminus with PRPF40A. Interacts with PQBP1, SETD2 and SYVN. Interacts with PFN1.INTERACTION: Q12873:CHD3; NbExp=3; IntAct=EBI-466029, EBI-523590; Q14194:CRMP1; NbExp=2; IntAct=EBI-466029, EBI-473101; Q13011:ECH1; NbExp=2; IntAct=EBI-466029, EBI-711968; Q99689:FEZ1; NbExp=3; IntAct=EBI-466029, EBI-396435; Q9Y2X7:GIT1; NbExp=10; IntAct=EBI-466029, EBI-466061; O95163:IKBKAP; NbExp=4; IntAct=EBI-466029, EBI-347559; Q9P2H0:KIAA1377; NbExp=2; IntAct=EBI-466029, EBI-473176; Q9Y3C7:MED31; NbExp=3; IntAct=EBI-466029, EBI-394707; O43312:MTSS1; NbExp=3; IntAct=EBI-466029, EBI-473954; Q14596:NBR1; NbExp=3; IntAct=EBI-466029, EBI-742698; Q13177:PAK2; NbExp=2; IntAct=EBI-466029, EBI-1045887; P35080:PFN2; NbExp=4; IntAct=EBI-466029, EBI-473138; Q8N2W9:PIAS4; NbExp=3; IntAct=EBI-466029, EBI-473160; O75400:PRPF40A; NbExp=3; IntAct=EBI-466029, EBI-473291; Q99963:SH3GL3; NbExp=4; IntAct=EBI-466029, EBI-473910; O14776:TCERG1; NbExp=3; IntAct=EBI-466029, EBI-473271; P04637:TP53; NbExp=4; IntAct=EBI-466029, EBI-366083; Q8IZQ1:WDFY3; NbExp=11; IntAct=EBI-466029, EBI-1569256; P12956:XRCC6; NbExp=3; IntAct=EBI-466029, EBI-353208;SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=The mutant Huntingtin protein colocalizes with AKAP8L in the nuclear matrix of Huntington disease neurons.TISSUE SPECIFICITY: Expressed in the brain cortex (at protein level). Widely expressed with the highest level of expression in the brain (nerve fibers, varicosities, and nerve endings). In the brain, the regions where it can be mainly found are the cerebellar cortex, the neocortex, the striatum, and the hippocampal formation.DOMAIN: The N-terminal Gln-rich and Pro-rich domain has great conformational flexibility and is likely to exist in a fluctuating equilibrium of alpha-helical, random coil, and extended conformations.PTM: Cleaved by apopain downstream of the polyglutamine stretch. The resulting N-terminal fragment is cytotoxic and provokes apoptosis.PTM: Forms with expanded polyglutamine expansion are specifically ubiquitinated by SYVN1, which promotes their proteasomal degradation.PTM: Phosphorylation at Ser-1179 and Ser-1199 by CDK5 in response to DNA damage in nuclei of neurons protects neurons against polyglutamine expansion as well as DNA damage mediated toxicity.POLYMORPHISM: The poly-Gln region of HTT is highly polymorphic (10 to 35 repeats) in the normal population and is expanded to about 36-120 repeats in Huntington disease patients. The repeat length usually increases in successive generations, but contracts also on occasion. The adjacent poly-Pro region is also polymorphic and varies between 7-12 residues. Polyglutamine expansion leads to elevated susceptibility to apopain cleavage and likely result in accelerated neuronal apoptosis.DISEASE: Defects in HTT are the cause of Huntington disease (HD) [MIM:143100] . HD is an autosomal dominant neurodegenerative disorder characterized by involuntary movements (chorea), general motor impairment, psychiatric disorders and dementia. Onset of the disease occurs usually in the third or fourth decade of life and symptoms progressively worsen leading to death in 10 to 20 years. Onset and clinical course depend on the degree of poly-Gln repeat expansion, longer expansions resulting in earlier onset and more severe clinical manifestations. HD affects 1 in 10,000 individuals of European origin. Neuropathology of Huntington disease displays a distinctive pattern with loss of neurons, especially in the caudate and putamen (striatum).SIMILARITY: Belongs to the huntingtin family.SIMILARITY: Contains 10 HEAT repeats.WEB RESOURCE: Name=GeneReviews; URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/HTT";WEB RESOURCE: Name=Wikipedia; Note=Huntingtin entry; URL="http://en.wikipedia.org/wiki/Huntingtin";
Primer design for this transcript
MalaCards Disease Associations
MalaCards Gene Search: HTT
Diseases sorted by gene-association score: huntington disease * (1459), lopes-maciel-rodan syndrome * (1200), spinocerebellar ataxia 1 (21), spinal and bulbar muscular atrophy of kennedy (18), choreatic disease (13), spastic paraplegia 38, autosomal dominant (11), huntington disease-like 2 (10), alexander disease (7), movement disease (7), leukodystrophy, hypomyelinating, 2 (4), nervous system disease (2), parkinson disease, late-onset (2), central nervous system disease (2), amyotrophic lateral sclerosis 1 (1)* = Manually curated disease association
Comparative Toxicogenomics Database (CTD)
Common Gene Haplotype Alleles
Press "+" in the title bar above to open this section.
RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
Microarray Expression Data
Press "+" in the title bar above to open this section.
mRNA Secondary Structure of 3' and 5' UTRs
Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.
Protein Domain and Structure Information
InterPro Domains: Graphical view of domain structure IPR011989 - ARM-likeIPR016024 - ARM-type_foldIPR000091 - HuntingtinIPR024613 - Huntingtin_middle-repeatPfam Domains: PF12372 - Huntingtin protein regionSCOP Domains: 48371 - ARM repeat48431 - Lipovitellin-phosvitin complex, superhelical domain101447 - Formin homology 2 domain (FH2 domain)81995 - beta-sandwich domain of Sec23/24Protein Data Bank (PDB) 3-D Structure ModBase Predicted Comparative 3D Structure on P42858 The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.
Orthologous Genes in Other Species
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Gene Ontology (GO) Annotations with Structured Vocabulary
Descriptions from all associated GenBank mRNAs
L12392 - Homo sapiens Huntington's Disease (HD) mRNA, complete cds.AB016794 - Homo sapiens mRNA for huntingtin, complete cds.JA482185 - Sequence 168 from Patent WO2011072091.JE980477 - Sequence 168 from Patent EP2862929.LF383963 - JP 2014500723-A/191466: Polycomb-Associated Non-Coding RNAs.BC172756 - Synthetic construct Homo sapiens clone IMAGE:9095601; MGC:199461 huntingtin (HTT) gene, encodes complete protein.KJ535072 - Homo sapiens clone HTT_iso-A_fetal-F12 huntingtin isoform A (HTT) mRNA, complete cds, alternatively spliced.AB209506 - Homo sapiens mRNA for huntingtin variant protein.MA619540 - JP 2018138019-A/191466: Polycomb-Associated Non-Coding RNAs.LQ581588 - Sequence 2 from Patent WO2016102664.LY526845 - KR 1020170120572-A/2: RNAI INDUCED HUNTINGTIN GENE SUPPRESSION.JD142386 - Sequence 123410 from Patent EP1572962.JD191827 - Sequence 172851 from Patent EP1572962.LQ651786 - Sequence 203 from Patent WO2016161374.LQ651683 - Sequence 100 from Patent WO2016161374.LQ651787 - Sequence 204 from Patent WO2016161374.LQ581635 - Sequence 49 from Patent WO2016102664.LY526892 - KR 1020170120572-A/49: RNAI INDUCED HUNTINGTIN GENE SUPPRESSION.LQ651684 - Sequence 101 from Patent WO2016161374.LQ581634 - Sequence 48 from Patent WO2016102664.LY526891 - KR 1020170120572-A/48: RNAI INDUCED HUNTINGTIN GENE SUPPRESSION.LQ581633 - Sequence 47 from Patent WO2016102664.LY526890 - KR 1020170120572-A/47: RNAI INDUCED HUNTINGTIN GENE SUPPRESSION.LQ581587 - Sequence 1 from Patent WO2016102664.JD458280 - Sequence 439304 from Patent EP1572962.JD458281 - Sequence 439305 from Patent EP1572962.JD458282 - Sequence 439306 from Patent EP1572962.LQ651789 - Sequence 206 from Patent WO2016161374.CS412559 - Sequence 56 from Patent WO2006031267.CS644967 - Sequence 56 from Patent WO2006083800.LQ651709 - Sequence 126 from Patent WO2016161374.LQ651686 - Sequence 103 from Patent WO2016161374.LQ651605 - Sequence 22 from Patent WO2016161374.LQ651790 - Sequence 207 from Patent WO2016161374.LQ651687 - Sequence 104 from Patent WO2016161374.LQ651791 - Sequence 208 from Patent WO2016161374.LQ651688 - Sequence 105 from Patent WO2016161374.LQ651792 - Sequence 209 from Patent WO2016161374.LQ651710 - Sequence 127 from Patent WO2016161374.LQ651689 - Sequence 106 from Patent WO2016161374.LQ651606 - Sequence 23 from Patent WO2016161374.LQ651793 - Sequence 210 from Patent WO2016161374.LQ651690 - Sequence 107 from Patent WO2016161374.LQ651794 - Sequence 211 from Patent WO2016161374.LQ651691 - Sequence 108 from Patent WO2016161374.LQ651607 - Sequence 24 from Patent WO2016161374.LQ651711 - Sequence 128 from Patent WO2016161374.LQ651608 - Sequence 25 from Patent WO2016161374.LQ651712 - Sequence 129 from Patent WO2016161374.LQ651713 - Sequence 130 from Patent WO2016161374.LQ651609 - Sequence 26 from Patent WO2016161374.LQ651610 - Sequence 27 from Patent WO2016161374.LQ651714 - Sequence 131 from Patent WO2016161374.LQ651611 - Sequence 28 from Patent WO2016161374.LQ651716 - Sequence 133 from Patent WO2016161374.LQ651718 - Sequence 135 from Patent WO2016161374.LF358208 - JP 2014500723-A/165711: Polycomb-Associated Non-Coding RNAs.LQ651590 - Sequence 7 from Patent WO2016161374.LQ651720 - Sequence 137 from Patent WO2016161374.LQ651721 - Sequence 138 from Patent WO2016161374.LQ651591 - Sequence 8 from Patent WO2016161374.LQ651617 - Sequence 34 from Patent WO2016161374.LQ651722 - Sequence 139 from Patent WO2016161374.LQ651618 - Sequence 35 from Patent WO2016161374.LQ651723 - Sequence 140 from Patent WO2016161374.LQ651619 - Sequence 36 from Patent WO2016161374.LQ651620 - Sequence 37 from Patent WO2016161374.LQ651696 - Sequence 113 from Patent WO2016161374.LQ651724 - Sequence 141 from Patent WO2016161374.LQ651592 - Sequence 9 from Patent WO2016161374.LQ651621 - Sequence 38 from Patent WO2016161374.LF358209 - JP 2014500723-A/165712: Polycomb-Associated Non-Coding RNAs.LQ651725 - Sequence 142 from Patent WO2016161374.LQ651622 - Sequence 39 from Patent WO2016161374.LQ651727 - Sequence 144 from Patent WO2016161374.LQ651728 - Sequence 145 from Patent WO2016161374.LQ651624 - Sequence 41 from Patent WO2016161374.LQ651698 - Sequence 115 from Patent WO2016161374.LQ651625 - Sequence 42 from Patent WO2016161374.LQ651594 - Sequence 11 from Patent WO2016161374.LQ651729 - Sequence 146 from Patent WO2016161374.LQ651730 - Sequence 147 from Patent WO2016161374.LQ651626 - Sequence 43 from Patent WO2016161374.LQ651627 - Sequence 44 from Patent WO2016161374.LQ651731 - Sequence 148 from Patent WO2016161374.LQ651699 - Sequence 116 from Patent WO2016161374.LQ651628 - Sequence 45 from Patent WO2016161374.LQ651595 - Sequence 12 from Patent WO2016161374.MA398268 - JP 2018516091-A/203: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398165 - JP 2018516091-A/100: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398269 - JP 2018516091-A/204: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398166 - JP 2018516091-A/101: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398271 - JP 2018516091-A/206: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398191 - JP 2018516091-A/126: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398168 - JP 2018516091-A/103: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398087 - JP 2018516091-A/22: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398272 - JP 2018516091-A/207: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398169 - JP 2018516091-A/104: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398273 - JP 2018516091-A/208: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398170 - JP 2018516091-A/105: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398274 - JP 2018516091-A/209: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398192 - JP 2018516091-A/127: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398171 - JP 2018516091-A/106: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398088 - JP 2018516091-A/23: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398275 - JP 2018516091-A/210: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398172 - JP 2018516091-A/107: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398276 - JP 2018516091-A/211: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398173 - JP 2018516091-A/108: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398089 - JP 2018516091-A/24: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398193 - JP 2018516091-A/128: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398090 - JP 2018516091-A/25: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398194 - JP 2018516091-A/129: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398195 - JP 2018516091-A/130: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398091 - JP 2018516091-A/26: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398092 - JP 2018516091-A/27: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398196 - JP 2018516091-A/131: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398093 - JP 2018516091-A/28: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398198 - JP 2018516091-A/133: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398200 - JP 2018516091-A/135: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398072 - JP 2018516091-A/7: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398202 - JP 2018516091-A/137: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398203 - JP 2018516091-A/138: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398073 - JP 2018516091-A/8: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398099 - JP 2018516091-A/34: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398204 - JP 2018516091-A/139: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398100 - JP 2018516091-A/35: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398205 - JP 2018516091-A/140: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398101 - JP 2018516091-A/36: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398102 - JP 2018516091-A/37: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398178 - JP 2018516091-A/113: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398206 - JP 2018516091-A/141: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398074 - JP 2018516091-A/9: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398103 - JP 2018516091-A/38: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398207 - JP 2018516091-A/142: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398104 - JP 2018516091-A/39: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398209 - JP 2018516091-A/144: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398210 - JP 2018516091-A/145: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398106 - JP 2018516091-A/41: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398180 - JP 2018516091-A/115: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398107 - JP 2018516091-A/42: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398076 - JP 2018516091-A/11: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398211 - JP 2018516091-A/146: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398212 - JP 2018516091-A/147: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398108 - JP 2018516091-A/43: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398109 - JP 2018516091-A/44: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398213 - JP 2018516091-A/148: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398181 - JP 2018516091-A/116: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398110 - JP 2018516091-A/45: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398077 - JP 2018516091-A/12: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA593785 - JP 2018138019-A/165711: Polycomb-Associated Non-Coding RNAs.MA593786 - JP 2018138019-A/165712: Polycomb-Associated Non-Coding RNAs.MP109952 - Sequence 16 from Patent WO2019043027.MP109951 - Sequence 15 from Patent WO2019043027.MB015727 - JP 2018502601-A/2: RNAI INDUCED HUNTINGTIN GENE SUPPRESSION.MB015774 - JP 2018502601-A/49: RNAI INDUCED HUNTINGTIN GENE SUPPRESSION.MB015773 - JP 2018502601-A/48: RNAI INDUCED HUNTINGTIN GENE SUPPRESSION.MB015772 - JP 2018502601-A/47: RNAI INDUCED HUNTINGTIN GENE SUPPRESSION.MB015726 - JP 2018502601-A/1: RNAI INDUCED HUNTINGTIN GENE SUPPRESSION.MP248037 - Sequence 1 from Patent EP3478842.MP248039 - Sequence 3 from Patent EP3478842.MP248044 - Sequence 8 from Patent EP3478842.MP248045 - Sequence 9 from Patent EP3478842.MP319153 - Sequence 2 from Patent EP3540063.MP319200 - Sequence 49 from Patent EP3540063.MP319199 - Sequence 48 from Patent EP3540063.MP319198 - Sequence 47 from Patent EP3540063.MP319152 - Sequence 1 from Patent EP3540063.LQ651732 - Sequence 149 from Patent WO2016161374.LF358216 - JP 2014500723-A/165719: Polycomb-Associated Non-Coding RNAs.LF358221 - JP 2014500723-A/165724: Polycomb-Associated Non-Coding RNAs.LF358222 - JP 2014500723-A/165725: Polycomb-Associated Non-Coding RNAs.LQ651733 - Sequence 150 from Patent WO2016161374.LQ651700 - Sequence 117 from Patent WO2016161374.LQ651630 - Sequence 47 from Patent WO2016161374.LQ651596 - Sequence 13 from Patent WO2016161374.LQ651734 - Sequence 151 from Patent WO2016161374.LQ651701 - Sequence 118 from Patent WO2016161374.LQ651735 - Sequence 152 from Patent WO2016161374.LQ651631 - Sequence 48 from Patent WO2016161374.LQ651597 - Sequence 14 from Patent WO2016161374.LQ651736 - Sequence 153 from Patent WO2016161374.LQ651632 - Sequence 49 from Patent WO2016161374.LQ651633 - Sequence 50 from Patent WO2016161374.LF358223 - JP 2014500723-A/165726: Polycomb-Associated Non-Coding RNAs.LF358224 - JP 2014500723-A/165727: Polycomb-Associated Non-Coding RNAs.LQ651738 - Sequence 155 from Patent WO2016161374.LQ651635 - Sequence 52 from Patent WO2016161374.DL492659 - Novel nucleic acids.LQ651739 - Sequence 156 from Patent WO2016161374.LQ651740 - Sequence 157 from Patent WO2016161374.LQ651636 - Sequence 53 from Patent WO2016161374.LQ651637 - Sequence 54 from Patent WO2016161374.LQ651638 - Sequence 55 from Patent WO2016161374.LQ651742 - Sequence 159 from Patent WO2016161374.LQ651743 - Sequence 160 from Patent WO2016161374.LQ651640 - Sequence 57 from Patent WO2016161374.LQ651744 - Sequence 161 from Patent WO2016161374.LQ651641 - Sequence 58 from Patent WO2016161374.LQ651745 - Sequence 162 from Patent WO2016161374.LQ651642 - Sequence 59 from Patent WO2016161374.LF358228 - JP 2014500723-A/165731: Polycomb-Associated Non-Coding RNAs.LQ651746 - Sequence 163 from Patent WO2016161374.LQ651643 - Sequence 60 from Patent WO2016161374.LQ651702 - Sequence 119 from Patent WO2016161374.LQ651598 - Sequence 15 from Patent WO2016161374.LQ651747 - Sequence 164 from Patent WO2016161374.LQ651644 - Sequence 61 from Patent WO2016161374.LF358232 - JP 2014500723-A/165735: Polycomb-Associated Non-Coding RNAs.LQ651703 - Sequence 120 from Patent WO2016161374.LQ651599 - Sequence 16 from Patent WO2016161374.LZ228084 - JP 2017522005-A/3: HUNTINGTON'S DISEASE THERAPEUTIC COMPOUNDS.LQ651704 - Sequence 121 from Patent WO2016161374.LQ651600 - Sequence 17 from Patent WO2016161374.AK290544 - Homo sapiens cDNA FLJ76709 complete cds, highly similar to Homo sapiens Huntington disease-associated protein (HD) mRNA.L20431 - Homo sapiens Huntington disease-associated protein (HD) mRNA, complete cds.LF358234 - JP 2014500723-A/165737: Polycomb-Associated Non-Coding RNAs.LF358235 - JP 2014500723-A/165738: Polycomb-Associated Non-Coding RNAs.LQ651646 - Sequence 63 from Patent WO2016161374.LQ651587 - Sequence 4 from Patent WO2016161374.JD089552 - Sequence 70576 from Patent EP1572962.JD457856 - Sequence 438880 from Patent EP1572962.JD545872 - Sequence 526896 from Patent EP1572962.JD346990 - Sequence 328014 from Patent EP1572962.JD479464 - Sequence 460488 from Patent EP1572962.JD533279 - Sequence 514303 from Patent EP1572962.JD288950 - Sequence 269974 from Patent EP1572962.JD467297 - Sequence 448321 from Patent EP1572962.JD290162 - Sequence 271186 from Patent EP1572962.JD182187 - Sequence 163211 from Patent EP1572962.JD455656 - Sequence 436680 from Patent EP1572962.JD423828 - Sequence 404852 from Patent EP1572962.JD156373 - Sequence 137397 from Patent EP1572962.JD453183 - Sequence 434207 from Patent EP1572962.JD126243 - Sequence 107267 from Patent EP1572962.JD449314 - Sequence 430338 from Patent EP1572962.JD437739 - Sequence 418763 from Patent EP1572962.JD394795 - Sequence 375819 from Patent EP1572962.JD141963 - Sequence 122987 from Patent EP1572962.JD394122 - Sequence 375146 from Patent EP1572962.LQ651706 - Sequence 123 from Patent WO2016161374.LQ651602 - Sequence 19 from Patent WO2016161374.LQ651750 - Sequence 167 from Patent WO2016161374.LQ651751 - Sequence 168 from Patent WO2016161374.LQ651647 - Sequence 64 from Patent WO2016161374.LQ651752 - Sequence 169 from Patent WO2016161374.LQ651707 - Sequence 124 from Patent WO2016161374.LQ651708 - Sequence 125 from Patent WO2016161374.LQ651603 - Sequence 20 from Patent WO2016161374.LQ651604 - Sequence 21 from Patent WO2016161374.LQ651753 - Sequence 170 from Patent WO2016161374.LQ651650 - Sequence 67 from Patent WO2016161374.LQ651754 - Sequence 171 from Patent WO2016161374.LQ651755 - Sequence 172 from Patent WO2016161374.LQ651652 - Sequence 69 from Patent WO2016161374.JD151237 - Sequence 132261 from Patent EP1572962.JD336182 - Sequence 317206 from Patent EP1572962.JD365841 - Sequence 346865 from Patent EP1572962.JD409711 - Sequence 390735 from Patent EP1572962.JD499378 - Sequence 480402 from Patent EP1572962.JD197620 - Sequence 178644 from Patent EP1572962.JD075416 - Sequence 56440 from Patent EP1572962.JD401372 - Sequence 382396 from Patent EP1572962.JD069648 - Sequence 50672 from Patent EP1572962.JD061288 - Sequence 42312 from Patent EP1572962.JD493934 - Sequence 474958 from Patent EP1572962.BC014028 - Homo sapiens huntingtin (Huntington disease), mRNA (cDNA clone IMAGE:4300144).JD432230 - Sequence 413254 from Patent EP1572962.JD058007 - Sequence 39031 from Patent EP1572962.LQ651756 - Sequence 173 from Patent WO2016161374.LQ651653 - Sequence 70 from Patent WO2016161374.JD123804 - Sequence 104828 from Patent EP1572962.JD393049 - Sequence 374073 from Patent EP1572962.JD075614 - Sequence 56638 from Patent EP1572962.JD225527 - Sequence 206551 from Patent EP1572962.JD471006 - Sequence 452030 from Patent EP1572962.LQ651757 - Sequence 174 from Patent WO2016161374.LQ651654 - Sequence 71 from Patent WO2016161374.LQ651758 - Sequence 175 from Patent WO2016161374.LQ651655 - Sequence 72 from Patent WO2016161374.LQ651759 - Sequence 176 from Patent WO2016161374.LQ651656 - Sequence 73 from Patent WO2016161374.LQ651760 - Sequence 177 from Patent WO2016161374.LQ651657 - Sequence 74 from Patent WO2016161374.JD054570 - Sequence 35594 from Patent EP1572962.JD323234 - Sequence 304258 from Patent EP1572962.JD497566 - Sequence 478590 from Patent EP1572962.LQ651761 - Sequence 178 from Patent WO2016161374.LQ651658 - Sequence 75 from Patent WO2016161374.JD340222 - Sequence 321246 from Patent EP1572962.LQ651762 - Sequence 179 from Patent WO2016161374.LQ651659 - Sequence 76 from Patent WO2016161374.LQ651763 - Sequence 180 from Patent WO2016161374.JD397607 - Sequence 378631 from Patent EP1572962.JD389794 - Sequence 370818 from Patent EP1572962.JD419126 - Sequence 400150 from Patent EP1572962.LQ651764 - Sequence 181 from Patent WO2016161374.LQ651765 - Sequence 182 from Patent WO2016161374.JD239377 - Sequence 220401 from Patent EP1572962.LQ651662 - Sequence 79 from Patent WO2016161374.LQ651766 - Sequence 183 from Patent WO2016161374.AK025918 - Homo sapiens cDNA: FLJ22265 fis, clone HRC03086, highly similar to HUMHUNTDIS Homo sapiens Huntington disease-associated protein (HD) mRNA.JD081985 - Sequence 63009 from Patent EP1572962.JD256323 - Sequence 237347 from Patent EP1572962.JD137315 - Sequence 118339 from Patent EP1572962.JD374948 - Sequence 355972 from Patent EP1572962.JD360771 - Sequence 341795 from Patent EP1572962.LQ651767 - Sequence 184 from Patent WO2016161374.LQ651768 - Sequence 185 from Patent WO2016161374.LQ651665 - Sequence 82 from Patent WO2016161374.JD090384 - Sequence 71408 from Patent EP1572962.LQ651769 - Sequence 186 from Patent WO2016161374.LQ651666 - Sequence 83 from Patent WO2016161374.LQ651770 - Sequence 187 from Patent WO2016161374.LQ651667 - Sequence 84 from Patent WO2016161374.JD252210 - Sequence 233234 from Patent EP1572962.LQ651771 - Sequence 188 from Patent WO2016161374.LQ651772 - Sequence 189 from Patent WO2016161374.LQ651669 - Sequence 86 from Patent WO2016161374.LQ651773 - Sequence 190 from Patent WO2016161374.LQ651670 - Sequence 87 from Patent WO2016161374.LQ651774 - Sequence 191 from Patent WO2016161374.LQ651671 - Sequence 88 from Patent WO2016161374.LQ651775 - Sequence 192 from Patent WO2016161374.LQ651776 - Sequence 193 from Patent WO2016161374.LQ651672 - Sequence 89 from Patent WO2016161374.LQ651673 - Sequence 90 from Patent WO2016161374.LQ651777 - Sequence 194 from Patent WO2016161374.LQ651778 - Sequence 195 from Patent WO2016161374.LQ651779 - Sequence 196 from Patent WO2016161374.LQ651676 - Sequence 93 from Patent WO2016161374.LQ651780 - Sequence 197 from Patent WO2016161374.LQ651677 - Sequence 94 from Patent WO2016161374.JD371812 - Sequence 352836 from Patent EP1572962.JD561876 - Sequence 542900 from Patent EP1572962.JD499177 - Sequence 480201 from Patent EP1572962.JD199264 - Sequence 180288 from Patent EP1572962.JD531590 - Sequence 512614 from Patent EP1572962.JD261892 - Sequence 242916 from Patent EP1572962.JD566132 - Sequence 547156 from Patent EP1572962.JD159161 - Sequence 140185 from Patent EP1572962.JD486443 - Sequence 467467 from Patent EP1572962.JD227030 - Sequence 208054 from Patent EP1572962.JD253865 - Sequence 234889 from Patent EP1572962.JD144804 - Sequence 125828 from Patent EP1572962.JD232226 - Sequence 213250 from Patent EP1572962.JD308997 - Sequence 290021 from Patent EP1572962.JD423879 - Sequence 404903 from Patent EP1572962.JD210866 - Sequence 191890 from Patent EP1572962.JD338834 - Sequence 319858 from Patent EP1572962.JD458261 - Sequence 439285 from Patent EP1572962.JD140693 - Sequence 121717 from Patent EP1572962.LQ651781 - Sequence 198 from Patent WO2016161374.LQ651678 - Sequence 95 from Patent WO2016161374.JD068145 - Sequence 49169 from Patent EP1572962.JD186486 - Sequence 167510 from Patent EP1572962.JD527188 - Sequence 508212 from Patent EP1572962.JD218132 - Sequence 199156 from Patent EP1572962.JD248311 - Sequence 229335 from Patent EP1572962.JD199358 - Sequence 180382 from Patent EP1572962.LQ651782 - Sequence 199 from Patent WO2016161374.LQ651679 - Sequence 96 from Patent WO2016161374.LQ651783 - Sequence 200 from Patent WO2016161374.LQ651680 - Sequence 97 from Patent WO2016161374.LQ651784 - Sequence 201 from Patent WO2016161374.LQ651681 - Sequence 98 from Patent WO2016161374.LQ651785 - Sequence 202 from Patent WO2016161374.JD299241 - Sequence 280265 from Patent EP1572962.LQ651682 - Sequence 99 from Patent WO2016161374.JD060219 - Sequence 41243 from Patent EP1572962.MA398214 - JP 2018516091-A/149: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398215 - JP 2018516091-A/150: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398182 - JP 2018516091-A/117: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398112 - JP 2018516091-A/47: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398078 - JP 2018516091-A/13: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398216 - JP 2018516091-A/151: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398183 - JP 2018516091-A/118: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398217 - JP 2018516091-A/152: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398113 - JP 2018516091-A/48: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398079 - JP 2018516091-A/14: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398218 - JP 2018516091-A/153: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398114 - JP 2018516091-A/49: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398115 - JP 2018516091-A/50: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398220 - JP 2018516091-A/155: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398117 - JP 2018516091-A/52: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398221 - JP 2018516091-A/156: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398222 - JP 2018516091-A/157: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398118 - JP 2018516091-A/53: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398119 - JP 2018516091-A/54: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398120 - JP 2018516091-A/55: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398224 - JP 2018516091-A/159: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398225 - JP 2018516091-A/160: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398122 - JP 2018516091-A/57: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398226 - JP 2018516091-A/161: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398123 - JP 2018516091-A/58: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398227 - JP 2018516091-A/162: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398124 - JP 2018516091-A/59: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398228 - JP 2018516091-A/163: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398125 - JP 2018516091-A/60: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398184 - JP 2018516091-A/119: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398080 - JP 2018516091-A/15: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398229 - JP 2018516091-A/164: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398126 - JP 2018516091-A/61: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398185 - JP 2018516091-A/120: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398081 - JP 2018516091-A/16: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398186 - JP 2018516091-A/121: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398082 - JP 2018516091-A/17: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398128 - JP 2018516091-A/63: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398069 - JP 2018516091-A/4: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398188 - JP 2018516091-A/123: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398084 - JP 2018516091-A/19: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398232 - JP 2018516091-A/167: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398233 - JP 2018516091-A/168: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398129 - JP 2018516091-A/64: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398234 - JP 2018516091-A/169: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398189 - JP 2018516091-A/124: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398190 - JP 2018516091-A/125: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398085 - JP 2018516091-A/20: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398086 - JP 2018516091-A/21: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398235 - JP 2018516091-A/170: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398132 - JP 2018516091-A/67: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398236 - JP 2018516091-A/171: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398237 - JP 2018516091-A/172: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398134 - JP 2018516091-A/69: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398238 - JP 2018516091-A/173: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398135 - JP 2018516091-A/70: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398239 - JP 2018516091-A/174: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398136 - JP 2018516091-A/71: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398240 - JP 2018516091-A/175: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398137 - JP 2018516091-A/72: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398241 - JP 2018516091-A/176: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398138 - JP 2018516091-A/73: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398242 - JP 2018516091-A/177: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398139 - JP 2018516091-A/74: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398243 - JP 2018516091-A/178: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398140 - JP 2018516091-A/75: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398244 - JP 2018516091-A/179: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398141 - JP 2018516091-A/76: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398245 - JP 2018516091-A/180: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398246 - JP 2018516091-A/181: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398247 - JP 2018516091-A/182: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398144 - JP 2018516091-A/79: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398248 - JP 2018516091-A/183: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398249 - JP 2018516091-A/184: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398250 - JP 2018516091-A/185: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398147 - JP 2018516091-A/82: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398251 - JP 2018516091-A/186: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398148 - JP 2018516091-A/83: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398252 - JP 2018516091-A/187: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398149 - JP 2018516091-A/84: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398253 - JP 2018516091-A/188: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398254 - JP 2018516091-A/189: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398151 - JP 2018516091-A/86: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398255 - JP 2018516091-A/190: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398152 - JP 2018516091-A/87: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398256 - JP 2018516091-A/191: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398153 - JP 2018516091-A/88: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398257 - JP 2018516091-A/192: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398258 - JP 2018516091-A/193: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398154 - JP 2018516091-A/89: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398155 - JP 2018516091-A/90: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398259 - JP 2018516091-A/194: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398260 - JP 2018516091-A/195: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398261 - JP 2018516091-A/196: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398158 - JP 2018516091-A/93: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398262 - JP 2018516091-A/197: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398159 - JP 2018516091-A/94: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398263 - JP 2018516091-A/198: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398160 - JP 2018516091-A/95: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398264 - JP 2018516091-A/199: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398161 - JP 2018516091-A/96: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398265 - JP 2018516091-A/200: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398162 - JP 2018516091-A/97: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398266 - JP 2018516091-A/201: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398163 - JP 2018516091-A/98: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398267 - JP 2018516091-A/202: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA398164 - JP 2018516091-A/99: OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA.MA593793 - JP 2018138019-A/165719: Polycomb-Associated Non-Coding RNAs.MA593798 - JP 2018138019-A/165724: Polycomb-Associated Non-Coding RNAs.MA593799 - JP 2018138019-A/165725: Polycomb-Associated Non-Coding RNAs.MA593800 - JP 2018138019-A/165726: Polycomb-Associated Non-Coding RNAs.MA593801 - JP 2018138019-A/165727: Polycomb-Associated Non-Coding RNAs.MA593805 - JP 2018138019-A/165731: Polycomb-Associated Non-Coding RNAs.MA593809 - JP 2018138019-A/165735: Polycomb-Associated Non-Coding RNAs.MA593811 - JP 2018138019-A/165737: Polycomb-Associated Non-Coding RNAs.MA593812 - JP 2018138019-A/165738: Polycomb-Associated Non-Coding RNAs.
Other Names for This Gene
Alternate Gene Symbols: ENST00000355072.1, ENST00000355072.10, ENST00000355072.2, ENST00000355072.3, ENST00000355072.4, ENST00000355072.5, ENST00000355072.6, ENST00000355072.7, ENST00000355072.8, ENST00000355072.9, HD, HD_HUMAN, IT15, NM_002111, P42858, Q9UQB7, uc317yxq.1, uc317yxq.2UCSC ID: ENST00000355072.11_5RefSeq Accession: NM_001388492.1 Protein: P42858
(aka HD_HUMAN)
GeneReviews for This Gene
GeneReviews article(s) related to gene HTT:huntington dystonia-ov
Gene Model Information
Click here
for a detailed description of the fields of the table above.
Methods, Credits, and Use Restrictions
Click here
for details on how this gene model was made and data restrictions if any.
US Server
Sequence and Links to Tools and Databases 
Common Gene Haplotype Alleles 
